Growth Metrics

Novartis Ag (NVS) Capital Expenditures Growth (5y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -7.06%
Dec 31, 2025 -3.17%
Sep 30, 2025 -4.88%
Jun 30, 2025 -6.82%
Mar 31, 2025 -1.40%
Dec 31, 2024 -3.89%
Sep 30, 2024 2.10%
Jun 30, 2024 1.40%
Mar 31, 2024 4.25%
Dec 31, 2023 1.77%
Sep 30, 2023 2.42%
Jun 30, 2023 2.62%
Mar 31, 2023 8.22%
Dec 31, 2022 13.67%
Sep 30, 2022 10.37%
Jun 30, 2022 4.99%
Mar 31, 2022 5.66%
Dec 31, 2021 4.73%
Sep 30, 2021 4.55%
Jun 30, 2021 6.45%
Mar 31, 2021 8.57%
Dec 31, 2020 7.10%
Sep 30, 2020 13.59%
Jun 30, 2020 -1,232.76%
Mar 31, 2020 -1,282.66%
Dec 31, 2019 -1,309.04%
Sep 30, 2019 -1,298.23%
Jun 30, 2019 -1,240.74%
Mar 31, 2019 -1,323.77%
Sep 30, 2018 -1,211.95%
Jun 30, 2018 -1,223.44%
Mar 31, 2018 -1,290.12%
Sep 30, 2017 -1,319.85%
Jun 30, 2017 -1,306.11%
Mar 31, 2017 -1,428.74%
Dec 31, 2016 -1,394.88%
Sep 30, 2016 -1,440.87%
Jun 30, 2016 -1,481.38%
Mar 31, 2016 -1,458.29%
Dec 31, 2015 -1,520.90%
Sep 30, 2015 -1,656.79%
Jun 30, 2015 -9.78%
Mar 31, 2015 -9.06%
Dec 31, 2014 -6.04%
Sep 30, 2014 -9.99%
Jun 30, 2014 -5.83%
Mar 31, 2014 -5.55%